PHARMA FLEX
ActiveSummary
PHARMA FLEX has been active since 2008 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €10.5m and a net result of €4.3m. Equity has been shrinking by about 3.4% per year since 2018. Its solvency ranks better than 88% of 384 sector peers (NACE 28, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Overview
Overview
Official details
Source: KBO- Status
- Active since 04-04-2008 Normal situation
- Activity
- Manufacture of machinery and equipment not elsewhere classified NACE 28990and 2 others
- Joint committee
- 200 Aanvullend Paritair Comité voor de bedienden · annual accounts 2025
- Establishment unit
- 2.172.568.782 1402 Nivelles, since 11-04-2008
- Financial year end
- 31 December
- Peppol
- Reachable since 21-10-2026
Board and ownership
- AdFines SrlDirector · since 09-02-2024
- ADFINITIS SRLDirector · since 09-02-2024 · permanent representative DOLLINGER Martial
- NextGen Invest SrlDirector · since 09-02-2024
- Auditor
- RdB SRL
- AdFinitis55%30-06-2025 annual accounts of AdFinitis
- NextGen Invest32%2025 annual accounts of NextGen Invest
- AdFines13%2025 annual accounts of AdFines
- Holdings
- Shares in 4 companies including PHARMA TECHNOLOGY - PHARMA FLEX GMBH and PHARMA TECHNOLOGY ASIA PACIFIC LTD
Financial position
- Bankruptcy probabilitywithin 12 months
- 0.1%
- Turnover
- €2.1m
- ▲ 10.4%
- Profit
- €4.3m
- ▼ 41.4%
- Equity
- €10.5m
- ▲ 7.9%
- Total assets
- €14.3m
- ▲ 3.3%
- Employees on 31-12-2025
- 4
- =
Score breakdownlowers riskFounded in 2008Size: turnover €2.1m, 3.8 FTE, total assets €14.3mFigures for financial year 2025 (filed on 27-03-2026)Equity €10.5m (73.3% of total assets)Show the evidence
Checked score
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 28, micro). It does better than 77% of them on solvency, 50% on liquidity, 63% on profitability and 62% on growth.
The bankruptcy probability was computed on 03-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 7 accounts on average 48 days before the deadline. In the sector (NACE 28), the median for financial year 2024 was 11 days before the deadline, and 32% of those companies filed late.
Searched, nothing found (2)
Financials
Financials · financial year 2025, full format
Annual accounts 2025 filed on 27-03-2026 PDF all 17 filings
Every figure per financial year
The operating result for 2025 is a profit of €38,946, after a loss of €5,349 in 2024.
Staff
| Item | 31-12-2021 | 31-12-2022 | 31-12-2023 | 31-12-2024 | 31-12-2025 |
|---|---|---|---|---|---|
| Employees at the balance-sheet date | 4 | 4 | - | 4 | 4 |
| full-time | 4 | 4 | - | 4 | 4 |
| in full-time equivalents | 4 | 4 | - | 4 | 4 |
| Average over the year, in full-time equivalents | 3.1 | 3.9 | 1 | 4.3 | 3.8 |
| On a permanent contract | 4 | 4 | - | 4 | 4 |
| Joined | 1 | 1 | 0 | 5 | 1 |
| Left | 0 | 1 | 4 | 1 | 1 |
| Agency workers, average number | - | - | - | 0.5 | 0.2 |
| Training hours | 24 | 8 | - | 100 | 102 |
Source: social balance sheet in the 2021 to 2025 annual accounts
Investments
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Tangible fixed assets | €642,311 | €632,852 | - | €184,030 | €860 |
| Intangible fixed assets | €390,926 | €183,578 | - | - | - |
| Financial fixed assets | - | - | - | €25,000 | - |
| Depreciation and write-downs of the year | €494,276 | €555,998 | €15,798 | €33,366 | €40,962 |
Source: notes to the 2021 to 2025 annual accounts (statement of fixed assets)
Auditor
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Fee for the audit | €5,400 | €6,480 | €6,480 | €6,480 | €8,550 |
Source: notes to the 2021 to 2025 annual accounts (relations with the auditor)
| Line | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|---|
| Operating income70/76A | - | - | - | €13.7m | €13.4m | €2.6m | €1.9m | €2.1m | ▲ 10.3% |
| Turnover70 | €12.2m | €13.4m | €11.5m | €13.2m | €12.7m | €2.3m | €1.9m | €2.1m | ▲ 10.4% |
| Own construction capitalised72 | - | - | - | €0.4m | €0.5m | - | - | - | - |
| Other operating income74 | - | - | - | €0.2m | €0.2m | €0.4m | €0.02m | €0.02m | ▼ 9.9% |
| Operating charges60/66A | - | - | - | €12.4m | €13.2m | €2.7m | €1.9m | €2.1m | ▲ 7.9% |
| Goods for resale, raw materials and consumables60 | - | - | - | €7.5m | €7.8m | €2.1m | €1.1m | €1.3m | ▲ 18.5% |
| Purchases600/8 | - | - | - | €7.5m | €7.8m | €2.1m | €1.1m | €1.3m | ▲ 18.5% |
| Services and other goods61 | - | - | - | €4.1m | €4.4m | €0.3m | €0.3m | €0.2m | ▼ 11.8% |
| Remuneration, social security and pensions62 | - | - | - | €0.3m | €0.5m | €0.1m | €0.5m | €0.5m | ▲ 5.0% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €0.04m | €0.03m | €0.3m | €0.5m | €0.6m | €0.02m | €0.03m | €0.04m | ▲ 22.8% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4 | - | - | - | - | €0.02m | €0.01m | -€0.02m | - | - |
| Other operating charges640/8 | - | - | - | €0.002m | €0.002m | €0.2m | €0.07m | €0.001m | ▼ 98.4% |
| Operating profit (loss)9901 | €1.4m | €1.8m | €0.7m | €1.3m | €0.2m | -€0.08m | -€0.005m | €0.04m | - |
| Financial income75/76B | - | - | - | €3.6m | €4.2m | €5.7m | €7.4m | €4.4m | ▼ 40.9% |
| Recurring financial income75 | €0.4m | €1.3m | €3.0m | €3.6m | €4.2m | €5.7m | €7.4m | €4.4m | ▼ 40.9% |
| Income from financial fixed assets750 | - | - | - | €3.1m | €3.5m | €5.3m | €7.2m | €4.4m | ▼ 39.8% |
| Income from current assets751 | - | - | - | €0.03m | €0.1m | €0.1m | €0.08m | €0.02m | ▼ 67.8% |
| Other financial income752/9 | - | - | - | €0.4m | €0.5m | €0.3m | €0.1m | €0.009m | ▼ 92.8% |
| Financial charges65/66B | - | - | - | €0.05m | €0.5m | €0.1m | €0.05m | €0.1m | ▲ 113% |
| Recurring financial charges65 | €0.03m | €0.1m | €0.2m | €0.05m | €0.5m | €0.1m | €0.05m | €0.1m | ▲ 113% |
| Debt charges650 | €0.001m | €0.001m | €0.02m | €0.03m | €0.04m | €0.02m | €0.02m | €0.005m | ▼ 76.1% |
| Write-downs on current assets other than stocks, contracts in progress and trade receivables: additions (reversals)651 | - | - | - | €0.01m | €0.4m | -€0.4m | -€0.05m | - | - |
| Other financial charges652/9 | - | - | - | €0.005m | €0.008m | €0.5m | €0.08m | €0.1m | ▲ 27.8% |
| Profit (loss) for the period before taxes9903 | €1.8m | €2.9m | €3.6m | €4.9m | €3.9m | €5.5m | €7.4m | €4.3m | ▼ 41.4% |
| Income taxes67/77 | €0.4m | €0.6m | €0.3m | €0.3m | €0.2m | €0.003m | €0.004m | €0.001m | ▼ 62.9% |
| Taxes670/3 | - | - | - | €0.4m | €0.2m | €0.003m | €0.01m | €0.001m | ▼ 90.8% |
| Tax adjustments and reversals of tax provisions77 | - | - | - | €0.08m | - | - | €0.01m | - | - |
| Profit (loss) for the period9904 | €1.3m | €2.3m | €3.3m | €4.6m | €3.7m | €5.5m | €7.4m | €4.3m | ▼ 41.4% |
| Transfer from tax-exempt reserves789 | - | - | - | - | - | - | €0.8m | - | - |
| Transfer to tax-exempt reserves689 | - | - | - | €0.8m | - | - | - | - | - |
| Profit (loss) for the period to be appropriated9905 | €1.3m | €2.3m | €3.3m | €3.7m | €3.7m | €5.5m | €8.2m | €4.3m | ▼ 47.4% |
| Line | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Total assets20/58 | €14.9m | €15.0m | €20.9m | €27.3m | €29.0m | €18.6m | €13.8m | €14.3m | ▲ 3.3% |
| Fixed assets21/28 | €8.6m | €8.6m | €13.8m | €14.3m | €14.5m | €11.3m | €11.2m | €11.2m | ▼ 0.3% |
| Intangible fixed assets21 | - | - | €2.4m | €2.4m | €2.2m | - | - | - | - |
| Tangible fixed assets22/27 | €0.1m | €0.1m | €0.4m | €0.9m | €1.3m | €0.3m | €0.2m | €0.1m | ▼ 24.4% |
| Plant, machinery and equipment23 | - | - | - | €0.2m | €0.4m | - | €0.002m | €0.002m | ▲ 9.4% |
| Furniture and vehicles24 | - | - | - | €0.09m | €0.06m | €0.04m | €0.2m | €0.1m | ▼ 24.8% |
| Leasing and similar rights25 | - | - | - | €0.05m | €0.02m | - | - | - | - |
| Other tangible fixed assets26 | - | - | - | €0.5m | €0.8m | €0.3m | - | - | - |
| Financial fixed assets28 | €8.5m | €8.5m | €11.0m | €11.0m | €11.0m | €11.0m | €11.0m | €11.0m | = |
| Affiliated companies280/1 | - | - | - | €11.0m | €11.0m | €11.0m | €11.0m | €11.0m | = |
| Participating interests280 | - | - | - | €11.0m | €11.0m | €11.0m | €11.0m | €11.0m | = |
| Other financial fixed assets284/8 | - | - | - | - | - | - | - | €0.002m | - |
| Amounts receivable and cash guarantees285/8 | - | - | - | - | - | - | - | €0.002m | - |
| Current assets29/58 | €6.2m | €6.4m | €7.1m | €13.0m | €14.5m | €7.3m | €2.7m | €3.2m | ▲ 18.9% |
| Amounts receivable after more than one year29 | - | - | - | €0.5m | €0.5m | - | - | - | - |
| Other amounts receivable291 | - | - | - | €0.5m | €0.5m | - | - | - | - |
| Amounts receivable within one year40/41 | €3.3m | €3.1m | €1.8m | €3.5m | €2.7m | €0.9m | €0.3m | €0.3m | ▼ 4.5% |
| Trade receivables40 | - | - | - | €3.1m | €2.5m | €0.3m | €0.09m | €0.2m | ▲ 165% |
| Other amounts receivable41 | - | - | - | €0.4m | €0.2m | €0.6m | €0.2m | €0.08m | ▼ 67.9% |
| Current investments50/53 | - | €0.8m | €2.6m | €3.1m | €5.5m | €4.5m | €1.3m | €1.3m | ▲ 2.4% |
| Other investments51/53 | - | - | - | €3.1m | €5.5m | €4.5m | €1.3m | €1.3m | ▲ 2.4% |
| Cash at bank and in hand54/58 | €2.9m | €2.4m | €2.7m | €5.9m | €5.6m | €1.9m | €1.0m | €1.5m | ▲ 46.8% |
| Deferred charges and accrued income490/1 | - | - | - | €0.03m | €0.1m | €0.007m | €0.02m | €0.02m | ▼ 3.6% |
| Equity and liabilities | |||||||||
| Total equity and liabilities10/49 | €14.9m | €15.0m | €20.9m | €27.3m | €29.0m | €18.6m | €13.8m | €14.3m | ▲ 3.3% |
| Equity10/15 | €11.5m | €13.8m | €17.1m | €21.7m | €20.9m | €6.1m | €9.7m | €10.5m | ▲ 7.9% |
| Contributions10/11 | €4.5m | €4.5m | €4.5m | €4.5m | €0.4m | €0.4m | €0.4m | €0.4m | = |
| Capital10 | - | - | - | €4.5m | €0.4m | €0.4m | €0.4m | €0.4m | = |
| Issued capital100 | - | - | - | €4.5m | €0.4m | €0.4m | €0.4m | €0.4m | = |
| Reserves13 | €0.5m | €0.5m | €0.5m | €1.3m | €0.9m | €0.9m | €0.9m | €0.9m | = |
| Non-distributable reserves130/1 | - | - | - | €0.5m | €0.05m | €0.05m | €0.05m | €0.05m | = |
| Legal reserve130 | - | - | - | €0.5m | €0.05m | €0.05m | €0.05m | €0.05m | = |
| Tax-exempt reserves132 | - | - | - | €0.8m | €0.8m | €0.8m | - | - | - |
| Distributable reserves133 | - | - | - | €0.03m | €0.03m | €0.03m | €0.9m | €0.9m | = |
| Profit (loss) carried forward14 | €6.5m | €8.9m | €12.1m | €15.9m | €19.5m | €4.8m | €8.4m | €9.2m | ▲ 9.1% |
| Amounts payable17/49 | €3.3m | €1.2m | €3.8m | €5.6m | €8.1m | €12.5m | €4.1m | €3.8m | ▼ 7.3% |
| Amounts payable after more than one year17 | €0.1m | €0.07m | €0.08m | €0.008m | - | - | €0.1m | €0.07m | ▼ 28.9% |
| Financial debts170/4 | - | - | - | €0.008m | - | - | €0.1m | €0.07m | ▼ 28.9% |
| Credit institutions173 | - | - | - | €0.008m | - | - | €0.1m | €0.07m | ▼ 28.9% |
| Amounts payable within one year42/48 | €3.1m | €1.1m | €3.7m | €5.5m | €8.0m | €12.4m | €4.0m | €3.8m | ▼ 6.5% |
| Current portion of amounts payable after more than one year42 | - | - | - | €0.08m | €0.008m | - | €0.03m | €0.03m | ▲ 3.2% |
| Financial debts43 | - | - | - | - | - | €0.003m | €0.001m | €0.002m | ▲ 149% |
| Credit institutions430/8 | - | - | - | - | - | €0.003m | €0.001m | €0.002m | ▲ 149% |
| Trade debts44 | €2.6m | €0.9m | €1.5m | €1.4m | €7.8m | €0.03m | €0.2m | €0.07m | ▼ 55.9% |
| Suppliers440/4 | - | - | - | €1.4m | €7.8m | €0.03m | €0.2m | €0.07m | ▼ 55.9% |
| Taxes, remuneration and social security45 | - | - | - | €0.1m | €0.1m | €0.002m | €0.05m | €0.08m | ▲ 55.0% |
| Taxes450/3 | - | - | - | €0.08m | €0.07m | - | €0.01m | €0.01m | ▲ 26.0% |
| Remuneration and social security454/9 | - | - | - | €0.03m | €0.04m | €0.002m | €0.04m | €0.07m | ▲ 62.3% |
| Other amounts payable47/48 | - | - | - | €4.0m | €0.02m | €12.4m | €3.8m | €3.6m | ▼ 5.3% |
| Accrued charges and deferred income492/3 | - | - | - | €0.1m | €0.2m | €0.1m | €0.01m | - | - |
| Line | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €1.3m | €2.3m | €3.3m | €4.6m | €3.7m | €5.5m | €7.4m | €4.3m | ▼ 41.4% |
| + Depreciation and write-downs630 | €0.04m | €0.03m | €0.3m | €0.5m | €0.6m | €0.02m | €0.03m | €0.04m | ▲ 22.8% |
| Operating cash flow (approximation) | €1.4m | €2.4m | €3.6m | €5.1m | €4.2m | €5.5m | €7.4m | €4.4m | ▼ 41.1% |
| Investment in fixed assets (approximation) | - | €0 | -€5.5m | -€1.0m | -€0.7m | €3.2m | €0.09m | -€0.002m | - |
| Change in cash | - | -€0.5m | €0.3m | €3.2m | -€0.3m | -€3.8m | -€0.8m | €0.5m | - |
A Belgian filing has no cash-flow statement. These rows are therefore an approximation, derived from the income statement and the balance-sheet moves.
Latest 10 of 17 filings with the National Bank
| Financial year | Type | Filed | Reference | Document |
|---|---|---|---|---|
| 31-12-2025 | full format | 27-03-2026 | 2026-00064309 | |
| 31-12-2024 | full format | 15-04-2025 | 2025-00069739 | |
| 31-12-2023 | full format | 19-06-2024 | 2024-00141667 | |
| 31-12-2022 | full format | 29-06-2023 | 2023-00190201 | |
| 31-12-2021 | full format | 28-07-2022 | 2022-20233866 | |
| 31-12-2020 | full format | 28-07-2021 | 2021-41700550 | |
| 31-12-2019 | full format | 10-07-2020 | 2020-28200099 | |
| 31-12-2018 | full format | 30-07-2019 | 2019-39800400 | |
| 31-12-2017 | full format | 24-07-2018 | 2018-37300481 | |
| 31-12-2016 | full format | 26-07-2017 | 2017-35900194 |
Board & ownership
Directors
Act of 26-10-2026Reappointment: Renaud de Borman,Réviseur d'entreprises-Bedrijfsrevisor (statutory auditor)
Board 3
Permanent representatives 1
Statutory auditor 1
Owners and capital
Shareholders
3 ownersChain of control
- AdFinitis
- PHARMA FLEX
Owners 3
-
55%
- Equity €10.4m Profit of €819,002 in 2025 (profit of €8.3m in 2024)32%
-
13%
Capital transactions
- DOLLINGER Martial Arthur Charles Benoit 155,048 shares
- BECKER Claire Andrée Ingrid 6,461 shares
- 09-02-2024 Capital stated in the deed · €400,000 · 24,000 shares
- 05-04-2022 Capital increase of €400,000 · to €4,900,000 · from reserves
- 05-04-2022 Capital reduction of €4,500,000 · to €400,000 · repaid to the shareholders
Mandate history
- Board
- Statutory auditor
- end not dated
| Name | Functions and periods |
|---|---|
| AdFines Srl |
|
| NextGen Invest Srl |
|
| ADFINITIS SRL |
|
| RdB SRL |
|
| DOLLINGER Martial Arthur Charles Benoit |
|
| BECKER Claire Andrée Ingrid |
|
| RENAUD DE BORMAN, REVISEUR D'ENTREPRISES-BEDRIJFSREVISOR |
|
Articles of association
- Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
- “Moitié cédant moitié acquéreurs au prorata, cessions entre vifs onéreuses ou gratuites volontaires ou forcées exclusion et retrait usufruit…”
Articles of association, deed of 09-02-2024 (in French)
Network & group
Holdings and subsidiaries
4 holdingsHoldings 4
Source for every holding own accounts 2025
- PHARMA TECHNOLOGY - PHARMA FLEX GMBHDEsubsidiaryEquity €51,597Result €22,714100%
- PHARMA TECHNOLOGY ASIA PACIFIC LTDCNsubsidiaryEquity HKD 8.9mResult HKD 2.2m100%
- PHARMA TECHNOLOGY INCUSsubsidiaryEquity USD 1.2mResult USD 135,258100%
- PHARMA TECHNOLOGYsubsidiaryEquity €16.3m Profit of €3.8m in 2025 (profit of €4.3m in 2024) Checked score 9799.96%
Companies at the same address
6 other companies- AdFinitis Registered office · since 2024 1012280815
- NextGen Invest Registered office · since 2024 1004718674
- DOLLIMMO BELGIUM Registered office · since 2021 0765300009
- PHARMA VAT UNIT Registered office · since 2016 0654817207
- DOLFINANCE Registered office · since 2010 0444022844
- PHARMA TECHNOLOGY Registered office · since 1992 0443803803
Connections & network
1 connected companyThe connected companies are in the list below.
Timeline
Acts, filings and financial milestones
26-10
Gazette deed
Reappointment: Renaud de Borman,Réviseur d'entreprises-Bedrijfsrevisor (statutory auditor)2 points ▸
- General meeting, 26-03-2025
- Auditor reappointment, Renaud de Borman,Réviseur d'entreprises-Bedrijfsrevisor (statutory auditor)
24-01
Gazette deed
Resignation: DOLLINGER Martial (director)Appointment: ADFINITIS SRL (director) · Power of attorney6 points ▸
- General meeting, 16-09-2024
- Director resignation, DOLLINGER Martial (director)
- Director appointment, ADFINITIS SRL (director)
- Power of attorney, FIDUCIAIRE DIGITALE SRL
- Power of attorney, Benoît Meurmans
- Power of attorney, Nicolas Widar
09-02
Gazette deed
Appointments: DOLLINGER Martial Arthur Charles Benoit (statutory director) and BECKER Claire Andrée Ingrid (statutory director)Shareholding · Auditor report · Kind of shares26 points ▸
- General meeting, 25-01-2024
- Other provision, “président,exerce également secrétaire et scrutateur, bureau del’assemblée” (deed in French)
- DOLLINGER Martial Arthur Charles Benoit holds 155,048 shares
- BECKER Claire Andrée Ingrid holds 6,461 shares
- Other provision, “registre des actions nominatives”, 161509 (deed in French)
- Other provision, “ordre du jour modification del’objet rapport, rapport del’organe d’administration exposant justification détaillée” (deed in French)
- Other provision, 24000, “division du nombre d’actions” (deed in French), mentioned 2 times in the deed
- Other provision, “création de classes d’actions A,B et C rapports, article 7:155 du Code des Sociétés et des Associations” (deed in French)
- Auditor report, “évaluer si données financières et comptables du rapport del’organe d’administration sont fidèles et suffisantes pour éclairer l’assemblée appelée à voter, commi…” (deed in French)
- Kind of shares, 13200, 7680
- Amendment of the articles
- Other provision, “pouvoirs spéciaux” (deed in French)
- The act holds 14 more points.
08-11
Gazette deed
Reappointment: Renaud de Borman,Réviseur d'entreprises-Bedrijfsrevisor (statutory auditor)Power of attorney3 points ▸
- General meeting, 30-06-2022
- Auditor reappointment, Renaud de Borman,Réviseur d'entreprises-Bedrijfsrevisor (statutory auditor)
- Power of attorney, I-FID FIDUCIAIRE DIGITALE SRL
05-04
Gazette deed
Capital & shares · Amendment of the articlesCapital increase · Capital · Capital decrease7 points ▸
- General meeting, “assemblée générale extraordinaire des actionnaires” (deed in French)
- Capital increase, €400,000
- Capital, €4,900,000
- Capital decrease, €4,500,000
- Amendment of the articles, 5
- Power of attorney, Olivier WATERKEYN
- Power of attorney
Show earlier events
Sources:Publications in the Belgian Official GazetteFilings with the National Bank
History
Company details
Register details
Identity
KBO recordRegistered office and establishments
Activities
NACEBEL 2025Codes under NACEBEL 2008
Invoicing and payment
Financial year and general meeting
Accounts at the NBBSites & property
Buildings and parcels at the address
| Cadastral parcel | Region | Area | Buildings | Height / floors |
|---|---|---|---|---|
| 25099D0044/00N000 | Wallonia | 1.2 ha | 1 · 6,513 m² | 9.2 m · 3 |